nodes	percent_of_prediction	percent_of_DWPC	metapath
L-DOPA—Methyldopa—hypertension	0.247	1	CrCtD
L-DOPA—restless legs syndrome—Clonidine—hypertension	0.151	1	CpDpCtD
L-DOPA—DRD3—hypertension	0.0596	0.591	CbGaD
L-DOPA—DDC—Methyldopa—hypertension	0.0425	0.221	CbGbCtD
L-DOPA—DRD2—hypertension	0.0412	0.409	CbGaD
L-DOPA—Aminosalicylic Acid—Methyldopa—hypertension	0.024	0.138	CrCrCtD
L-DOPA—Carbidopa—Methyldopa—hypertension	0.0181	0.104	CrCrCtD
L-DOPA—Mesalazine—Methyldopa—hypertension	0.0167	0.0961	CrCrCtD
L-DOPA—Isoetarine—Methyldopa—hypertension	0.0167	0.0961	CrCrCtD
L-DOPA—Droxidopa—Methyldopa—hypertension	0.0156	0.0896	CrCrCtD
L-DOPA—Dopamine—Methyldopa—hypertension	0.0156	0.0896	CrCrCtD
L-DOPA—Norepinephrine—Methyldopa—hypertension	0.0156	0.0896	CrCrCtD
L-DOPA—DRD5—Fenoldopam—hypertension	0.0154	0.0801	CbGbCtD
L-DOPA—Levonordefrin—Methyldopa—hypertension	0.0147	0.084	CrCrCtD
L-DOPA—Epinephrine—Methyldopa—hypertension	0.0118	0.0678	CrCrCtD
L-DOPA—SLC15A1—Quinapril—hypertension	0.0116	0.0603	CbGbCtD
L-DOPA—SLC15A1—Fosinopril—hypertension	0.0116	0.0603	CbGbCtD
L-DOPA—SLC15A1—Benazepril—hypertension	0.0103	0.0537	CbGbCtD
L-DOPA—SLC15A1—Methyldopa—hypertension	0.0103	0.0537	CbGbCtD
L-DOPA—SLC15A1—Moexipril—hypertension	0.0103	0.0537	CbGbCtD
L-DOPA—Isoprenaline—Methyldopa—hypertension	0.00962	0.0552	CrCrCtD
L-DOPA—Isoprenaline—Pindolol—hypertension	0.00837	0.048	CrCrCtD
L-DOPA—DRD1—Fenoldopam—hypertension	0.00785	0.0409	CbGbCtD
L-DOPA—SLC15A1—Trandolapril—hypertension	0.00781	0.0407	CbGbCtD
L-DOPA—Isoprenaline—Labetalol—hypertension	0.00742	0.0425	CrCrCtD
L-DOPA—SLC15A1—Perindopril—hypertension	0.00714	0.0372	CbGbCtD
L-DOPA—SLC15A1—Lisinopril—hypertension	0.00592	0.0309	CbGbCtD
L-DOPA—SLC15A1—Enalapril—hypertension	0.00592	0.0309	CbGbCtD
L-DOPA—SLC15A1—Ramipril—hypertension	0.00592	0.0309	CbGbCtD
L-DOPA—DRD2—Fenoldopam—hypertension	0.00477	0.0249	CbGbCtD
L-DOPA—SLC15A1—Captopril—hypertension	0.00443	0.0231	CbGbCtD
L-DOPA—CYP2D6—Nebivolol—hypertension	0.00238	0.0124	CbGbCtD
L-DOPA—CYP2D6—Labetalol—hypertension	0.00238	0.0124	CbGbCtD
L-DOPA—CYP2D6—Acebutolol—hypertension	0.00218	0.0114	CbGbCtD
L-DOPA—CYP2D6—Metoprolol—hypertension	0.00203	0.0106	CbGbCtD
L-DOPA—CYP2D6—Pindolol—hypertension	0.00203	0.0106	CbGbCtD
L-DOPA—CYP2D6—Betaxolol—hypertension	0.00181	0.00942	CbGbCtD
L-DOPA—CYP2D6—Doxazosin—hypertension	0.00159	0.00829	CbGbCtD
L-DOPA—CYP2D6—Diltiazem—hypertension	0.00154	0.00801	CbGbCtD
L-DOPA—CYP2D6—Bepridil—hypertension	0.00137	0.00714	CbGbCtD
L-DOPA—CYP2D6—Irbesartan—hypertension	0.00125	0.00653	CbGbCtD
L-DOPA—CYP2D6—Amlodipine—hypertension	0.00123	0.0064	CbGbCtD
L-DOPA—CYP2D6—Felodipine—hypertension	0.00118	0.00617	CbGbCtD
L-DOPA—CYP2D6—Timolol—hypertension	0.00116	0.00607	CbGbCtD
L-DOPA—CYP2D6—Nifedipine—hypertension	0.00114	0.00597	CbGbCtD
L-DOPA—CYP2D6—Carvedilol—hypertension	0.00113	0.00588	CbGbCtD
L-DOPA—CYP2D6—Nicardipine—hypertension	0.00113	0.00588	CbGbCtD
L-DOPA—CYP2D6—Propranolol—hypertension	0.00104	0.00541	CbGbCtD
L-DOPA—CYP2D6—Captopril—hypertension	0.00102	0.00534	CbGbCtD
L-DOPA—CYP2D6—Clonidine—hypertension	0.000989	0.00516	CbGbCtD
L-DOPA—CYP2D6—Atorvastatin—hypertension	0.000882	0.0046	CbGbCtD
L-DOPA—CYP2D6—Verapamil—hypertension	0.000712	0.00371	CbGbCtD
L-DOPA—PSIP1—cardiac ventricle—hypertension	0.000694	0.0493	CbGeAlD
L-DOPA—PSIP1—myocardium—hypertension	0.000653	0.0464	CbGeAlD
L-DOPA—PSIP1—brainstem—hypertension	0.000527	0.0374	CbGeAlD
L-DOPA—PSIP1—nephron tubule—hypertension	0.000479	0.034	CbGeAlD
L-DOPA—PSIP1—heart—hypertension	0.000456	0.0324	CbGeAlD
L-DOPA—PSIP1—decidua—hypertension	0.000443	0.0315	CbGeAlD
L-DOPA—PSIP1—cardiovascular system—hypertension	0.00043	0.0305	CbGeAlD
L-DOPA—PSIP1—cortex of kidney—hypertension	0.00041	0.0291	CbGeAlD
L-DOPA—DRD4—heart—hypertension	0.000379	0.0269	CbGeAlD
L-DOPA—PSIP1—medulla oblongata—hypertension	0.000368	0.0261	CbGeAlD
L-DOPA—PSIP1—adrenal gland—hypertension	0.00034	0.0242	CbGeAlD
L-DOPA—SLC7A8—nephron tubule—hypertension	0.000316	0.0224	CbGeAlD
L-DOPA—DDC—brainstem—hypertension	0.000301	0.0213	CbGeAlD
L-DOPA—SLC7A8—heart—hypertension	0.0003	0.0213	CbGeAlD
L-DOPA—PSIP1—endocrine gland—hypertension	0.000295	0.0209	CbGeAlD
L-DOPA—SLC7A8—decidua—hypertension	0.000292	0.0207	CbGeAlD
L-DOPA—SLC7A8—kidney—hypertension	0.000277	0.0197	CbGeAlD
L-DOPA—DDC—nephron tubule—hypertension	0.000273	0.0194	CbGeAlD
L-DOPA—SLC7A8—cortex of kidney—hypertension	0.00027	0.0192	CbGeAlD
L-DOPA—PSIP1—central nervous system—hypertension	0.000266	0.0189	CbGeAlD
L-DOPA—CYP2D6—urine—hypertension	0.000265	0.0188	CbGeAlD
L-DOPA—SLC7A5—nephron tubule—hypertension	0.000245	0.0174	CbGeAlD
L-DOPA—DDC—kidney—hypertension	0.00024	0.017	CbGeAlD
L-DOPA—DDC—cortex of kidney—hypertension	0.000234	0.0166	CbGeAlD
L-DOPA—SLC7A5—heart—hypertension	0.000233	0.0165	CbGeAlD
L-DOPA—SLC7A5—smooth muscle tissue—hypertension	0.000231	0.0164	CbGeAlD
L-DOPA—SLC7A5—decidua—hypertension	0.000226	0.0161	CbGeAlD
L-DOPA—SLC7A8—adrenal gland—hypertension	0.000224	0.0159	CbGeAlD
L-DOPA—DRD1—brainstem—hypertension	0.000221	0.0157	CbGeAlD
L-DOPA—SLC7A5—cardiovascular system—hypertension	0.00022	0.0156	CbGeAlD
L-DOPA—SLC7A5—cortex of kidney—hypertension	0.000209	0.0149	CbGeAlD
L-DOPA—SLC15A1—nephron tubule—hypertension	0.000203	0.0144	CbGeAlD
L-DOPA—SLC7A5—cardiac atrium—hypertension	0.000199	0.0141	CbGeAlD
L-DOPA—SLC7A8—endocrine gland—hypertension	0.000194	0.0138	CbGeAlD
L-DOPA—DDC—adrenal gland—hypertension	0.000194	0.0138	CbGeAlD
L-DOPA—SLC7A5—medulla oblongata—hypertension	0.000188	0.0133	CbGeAlD
L-DOPA—SLC16A10—nephron tubule—hypertension	0.000187	0.0133	CbGeAlD
L-DOPA—SLC15A1—kidney—hypertension	0.000178	0.0127	CbGeAlD
L-DOPA—SLC7A8—central nervous system—hypertension	0.000175	0.0124	CbGeAlD
L-DOPA—SLC7A5—adrenal gland—hypertension	0.000174	0.0123	CbGeAlD
L-DOPA—DDC—endocrine gland—hypertension	0.000168	0.0119	CbGeAlD
L-DOPA—DRD5—endocrine gland—hypertension	0.000162	0.0115	CbGeAlD
L-DOPA—SLC16A10—cortex of kidney—hypertension	0.00016	0.0114	CbGeAlD
L-DOPA—DRD3—central nervous system—hypertension	0.000156	0.011	CbGeAlD
L-DOPA—Masoprocol—CYP2J2—hypertension	0.000155	0.0754	CrCbGaD
L-DOPA—DDC—central nervous system—hypertension	0.000152	0.0108	CbGeAlD
L-DOPA—SLC7A5—endocrine gland—hypertension	0.000151	0.0107	CbGeAlD
L-DOPA—DRD5—central nervous system—hypertension	0.000146	0.0104	CbGeAlD
L-DOPA—Mimosine—CCL2—hypertension	0.000141	0.0688	CrCbGaD
L-DOPA—L-Tryptophan—TPH1—hypertension	0.00014	0.0682	CrCbGaD
L-DOPA—SLC7A5—central nervous system—hypertension	0.000136	0.00964	CbGeAlD
L-DOPA—DRD2—brainstem—hypertension	0.00013	0.00926	CbGeAlD
L-DOPA—SLC15A1—endocrine gland—hypertension	0.000125	0.00888	CbGeAlD
L-DOPA—SLC16A10—endocrine gland—hypertension	0.000115	0.00819	CbGeAlD
L-DOPA—Mesalazine—IKBKB—hypertension	0.000113	0.055	CrCbGaD
L-DOPA—DRD1—central nervous system—hypertension	0.000111	0.00791	CbGeAlD
L-DOPA—Isoprenaline—PIK3R1—hypertension	9.11e-05	0.0443	CrCbGaD
L-DOPA—CYP2D6—brainstem—hypertension	7.84e-05	0.00557	CbGeAlD
L-DOPA—DRD2—endocrine gland—hypertension	7.3e-05	0.00518	CbGeAlD
L-DOPA—Isoprenaline—ADRBK1—hypertension	6.59e-05	0.0321	CrCbGaD
L-DOPA—DRD2—central nervous system—hypertension	6.58e-05	0.00467	CbGeAlD
L-DOPA—CYP2D6—kidney—hypertension	6.26e-05	0.00444	CbGeAlD
L-DOPA—L-Tyrosine—TH—hypertension	6.07e-05	0.0295	CrCbGaD
L-DOPA—Dopamine—DBH—hypertension	5.95e-05	0.0289	CrCbGaD
L-DOPA—Masoprocol—ALOX5—hypertension	5.56e-05	0.027	CrCbGaD
L-DOPA—Epinephrine—ADRBK1—hypertension	5.54e-05	0.0269	CrCbGaD
L-DOPA—Levonordefrin—ADRA2B—hypertension	5.31e-05	0.0258	CrCbGaD
L-DOPA—Aminosalicylic Acid—ALOX5—hypertension	5.16e-05	0.0251	CrCbGaD
L-DOPA—Levonordefrin—SLC6A2—hypertension	4.66e-05	0.0227	CrCbGaD
L-DOPA—CYP2D6—endocrine gland—hypertension	4.39e-05	0.00312	CbGeAlD
L-DOPA—Methyldopa—COMT—hypertension	4.12e-05	0.02	CrCbGaD
L-DOPA—Mesalazine—ALOX5—hypertension	4.05e-05	0.0197	CrCbGaD
L-DOPA—CYP2D6—central nervous system—hypertension	3.95e-05	0.00281	CbGeAlD
L-DOPA—Droxidopa—ADRA2B—hypertension	3.74e-05	0.0182	CrCbGaD
L-DOPA—Isoetarine—ADRB1—hypertension	3.58e-05	0.0174	CrCbGaD
L-DOPA—L-Phenylalanine—TH—hypertension	3.52e-05	0.0171	CrCbGaD
L-DOPA—Aminosalicylic Acid—MPO—hypertension	3.33e-05	0.0162	CrCbGaD
L-DOPA—Droxidopa—SLC6A2—hypertension	3.29e-05	0.016	CrCbGaD
L-DOPA—Levonordefrin—ADRA1A—hypertension	3.29e-05	0.016	CrCbGaD
L-DOPA—Norepinephrine—ADRA2B—hypertension	3.15e-05	0.0153	CrCbGaD
L-DOPA—Isoetarine—ADRB2—hypertension	3.01e-05	0.0147	CrCbGaD
L-DOPA—Masoprocol—CYP19A1—hypertension	2.92e-05	0.0142	CrCbGaD
L-DOPA—Epinephrine—ADRA2B—hypertension	2.86e-05	0.0139	CrCbGaD
L-DOPA—Norepinephrine—SLC6A2—hypertension	2.77e-05	0.0135	CrCbGaD
L-DOPA—Methyldopa—ADRA2A—hypertension	2.63e-05	0.0128	CrCbGaD
L-DOPA—Mesalazine—MPO—hypertension	2.61e-05	0.0127	CrCbGaD
L-DOPA—Dopamine—SLC6A2—hypertension	2.57e-05	0.0125	CrCbGaD
L-DOPA—Levonordefrin—ADRA2A—hypertension	2.33e-05	0.0113	CrCbGaD
L-DOPA—Mesalazine—PPARG—hypertension	2.32e-05	0.0113	CrCbGaD
L-DOPA—Droxidopa—ADRA1A—hypertension	2.32e-05	0.0113	CrCbGaD
L-DOPA—Aminosalicylic Acid—PTGS1—hypertension	2.18e-05	0.0106	CrCbGaD
L-DOPA—Dopamine—COMT—hypertension	2.01e-05	0.00979	CrCbGaD
L-DOPA—Norepinephrine—ADRA1A—hypertension	1.95e-05	0.00948	CrCbGaD
L-DOPA—Epinephrine—ADRA1A—hypertension	1.77e-05	0.0086	CrCbGaD
L-DOPA—Mesalazine—PTGS1—hypertension	1.71e-05	0.00833	CrCbGaD
L-DOPA—Droxidopa—ADRA2A—hypertension	1.64e-05	0.00797	CrCbGaD
L-DOPA—Droxidopa—ADRB1—hypertension	1.64e-05	0.00797	CrCbGaD
L-DOPA—Dopamine—HTR7—hypertension	1.5e-05	0.00728	CrCbGaD
L-DOPA—Isoprenaline—ADRB1—hypertension	1.49e-05	0.00724	CrCbGaD
L-DOPA—Dopamine—DRD3—hypertension	1.41e-05	0.00684	CrCbGaD
L-DOPA—Norepinephrine—ADRA2A—hypertension	1.38e-05	0.00671	CrCbGaD
L-DOPA—Norepinephrine—ADRB1—hypertension	1.38e-05	0.0067	CrCbGaD
L-DOPA—Droxidopa—ADRB2—hypertension	1.38e-05	0.0067	CrCbGaD
L-DOPA—Dopamine—SLC6A3—hypertension	1.31e-05	0.00637	CrCbGaD
L-DOPA—Dopamine—ADRB1—hypertension	1.28e-05	0.00623	CrCbGaD
L-DOPA—Epinephrine—ADRA2A—hypertension	1.25e-05	0.00609	CrCbGaD
L-DOPA—Isoprenaline—ADRB2—hypertension	1.25e-05	0.00609	CrCbGaD
L-DOPA—Epinephrine—ADRB1—hypertension	1.25e-05	0.00608	CrCbGaD
L-DOPA—Aminosalicylic Acid—PTGS2—hypertension	1.25e-05	0.00607	CrCbGaD
L-DOPA—Epinephrine—TNF—hypertension	1.19e-05	0.00577	CrCbGaD
L-DOPA—Norepinephrine—ADRB2—hypertension	1.16e-05	0.00564	CrCbGaD
L-DOPA—Isoprenaline—CYP1A1—hypertension	1.07e-05	0.00522	CrCbGaD
L-DOPA—Epinephrine—ADRB2—hypertension	1.05e-05	0.00512	CrCbGaD
L-DOPA—Norepinephrine—DRD2—hypertension	1.05e-05	0.00509	CrCbGaD
L-DOPA—Mesalazine—PTGS2—hypertension	9.79e-06	0.00476	CrCbGaD
L-DOPA—Dopamine—SLC6A4—hypertension	9.78e-06	0.00476	CrCbGaD
L-DOPA—Dopamine—DRD2—hypertension	9.73e-06	0.00473	CrCbGaD
L-DOPA—Gastrointestinal pain—Furosemide—hypertension	8.65e-06	0.000119	CcSEcCtD
L-DOPA—Rash—Eplerenone—hypertension	8.64e-06	0.000119	CcSEcCtD
L-DOPA—Urticaria—Perindopril—hypertension	8.64e-06	0.000119	CcSEcCtD
L-DOPA—Headache—Fosinopril—hypertension	8.64e-06	0.000119	CcSEcCtD
L-DOPA—Hypersensitivity—Trandolapril—hypertension	8.64e-06	0.000119	CcSEcCtD
L-DOPA—Dermatitis—Eplerenone—hypertension	8.64e-06	0.000119	CcSEcCtD
L-DOPA—Diarrhoea—Valsartan—hypertension	8.63e-06	0.000119	CcSEcCtD
L-DOPA—Asthenia—Clonidine—hypertension	8.63e-06	0.000119	CcSEcCtD
L-DOPA—Feeling abnormal—Betaxolol—hypertension	8.63e-06	0.000119	CcSEcCtD
L-DOPA—Confusional state—Timolol—hypertension	8.62e-06	0.000119	CcSEcCtD
L-DOPA—Vomiting—Verapamil—hypertension	8.62e-06	0.000119	CcSEcCtD
L-DOPA—Urticaria—Irbesartan—hypertension	8.61e-06	0.000119	CcSEcCtD
L-DOPA—Shock—Ramipril—hypertension	8.61e-06	0.000119	CcSEcCtD
L-DOPA—Hypersensitivity—Enalapril—hypertension	8.61e-06	0.000119	CcSEcCtD
L-DOPA—Abdominal pain—Perindopril—hypertension	8.6e-06	0.000119	CcSEcCtD
L-DOPA—Palpitations—Lisinopril—hypertension	8.59e-06	0.000119	CcSEcCtD
L-DOPA—Diarrhoea—Olmesartan—hypertension	8.59e-06	0.000119	CcSEcCtD
L-DOPA—Headache—Eplerenone—hypertension	8.59e-06	0.000119	CcSEcCtD
L-DOPA—Rash—Nifedipine—hypertension	8.58e-06	0.000118	CcSEcCtD
L-DOPA—Dermatitis—Nifedipine—hypertension	8.57e-06	0.000118	CcSEcCtD
L-DOPA—Abdominal pain—Irbesartan—hypertension	8.57e-06	0.000118	CcSEcCtD
L-DOPA—Thrombocytopenia—Ramipril—hypertension	8.57e-06	0.000118	CcSEcCtD
L-DOPA—Oedema—Timolol—hypertension	8.55e-06	0.000118	CcSEcCtD
L-DOPA—Loss of consciousness—Lisinopril—hypertension	8.54e-06	0.000118	CcSEcCtD
L-DOPA—Rash—Verapamil—hypertension	8.54e-06	0.000118	CcSEcCtD
L-DOPA—Urticaria—Hydrochlorothiazide—hypertension	8.54e-06	0.000118	CcSEcCtD
L-DOPA—Dermatitis—Verapamil—hypertension	8.54e-06	0.000118	CcSEcCtD
L-DOPA—Headache—Nifedipine—hypertension	8.53e-06	0.000118	CcSEcCtD
L-DOPA—Pruritus—Clonidine—hypertension	8.51e-06	0.000117	CcSEcCtD
L-DOPA—Abdominal pain—Hydrochlorothiazide—hypertension	8.5e-06	0.000117	CcSEcCtD
L-DOPA—Headache—Verapamil—hypertension	8.49e-06	0.000117	CcSEcCtD
L-DOPA—Hypersensitivity—Telmisartan—hypertension	8.49e-06	0.000117	CcSEcCtD
L-DOPA—Cough—Lisinopril—hypertension	8.48e-06	0.000117	CcSEcCtD
L-DOPA—Nausea—Diltiazem—hypertension	8.47e-06	0.000117	CcSEcCtD
L-DOPA—Nausea—Indapamide—hypertension	8.47e-06	0.000117	CcSEcCtD
L-DOPA—Hyperhidrosis—Ramipril—hypertension	8.46e-06	0.000117	CcSEcCtD
L-DOPA—Asthenia—Trandolapril—hypertension	8.41e-06	0.000116	CcSEcCtD
L-DOPA—Shock—Timolol—hypertension	8.41e-06	0.000116	CcSEcCtD
L-DOPA—Feeling abnormal—Losartan—hypertension	8.41e-06	0.000116	CcSEcCtD
L-DOPA—Urticaria—Furosemide—hypertension	8.4e-06	0.000116	CcSEcCtD
L-DOPA—Nausea—Carvedilol—hypertension	8.39e-06	0.000116	CcSEcCtD
L-DOPA—Asthenia—Enalapril—hypertension	8.38e-06	0.000116	CcSEcCtD
L-DOPA—Abdominal pain—Furosemide—hypertension	8.36e-06	0.000115	CcSEcCtD
L-DOPA—Gastrointestinal pain—Losartan—hypertension	8.34e-06	0.000115	CcSEcCtD
L-DOPA—Dizziness—Valsartan—hypertension	8.34e-06	0.000115	CcSEcCtD
L-DOPA—Anorexia—Ramipril—hypertension	8.34e-06	0.000115	CcSEcCtD
L-DOPA—Urticaria—Betaxolol—hypertension	8.32e-06	0.000115	CcSEcCtD
L-DOPA—Dizziness—Olmesartan—hypertension	8.3e-06	0.000115	CcSEcCtD
L-DOPA—Pruritus—Trandolapril—hypertension	8.3e-06	0.000115	CcSEcCtD
L-DOPA—Nausea—Doxazosin—hypertension	8.29e-06	0.000115	CcSEcCtD
L-DOPA—Chest pain—Lisinopril—hypertension	8.28e-06	0.000114	CcSEcCtD
L-DOPA—Hyperhidrosis—Timolol—hypertension	8.27e-06	0.000114	CcSEcCtD
L-DOPA—Asthenia—Telmisartan—hypertension	8.27e-06	0.000114	CcSEcCtD
L-DOPA—Pruritus—Enalapril—hypertension	8.26e-06	0.000114	CcSEcCtD
L-DOPA—Anxiety—Lisinopril—hypertension	8.25e-06	0.000114	CcSEcCtD
L-DOPA—Diarrhoea—Clonidine—hypertension	8.23e-06	0.000114	CcSEcCtD
L-DOPA—Nausea—Fosinopril—hypertension	8.19e-06	0.000113	CcSEcCtD
L-DOPA—Discomfort—Lisinopril—hypertension	8.18e-06	0.000113	CcSEcCtD
L-DOPA—Hypotension—Ramipril—hypertension	8.17e-06	0.000113	CcSEcCtD
L-DOPA—Anorexia—Timolol—hypertension	8.15e-06	0.000113	CcSEcCtD
L-DOPA—Pruritus—Telmisartan—hypertension	8.15e-06	0.000113	CcSEcCtD
L-DOPA—Nausea—Eplerenone—hypertension	8.14e-06	0.000112	CcSEcCtD
L-DOPA—Urticaria—Losartan—hypertension	8.11e-06	0.000112	CcSEcCtD
L-DOPA—Dry mouth—Lisinopril—hypertension	8.09e-06	0.000112	CcSEcCtD
L-DOPA—Nausea—Nifedipine—hypertension	8.08e-06	0.000112	CcSEcCtD
L-DOPA—Abdominal pain—Losartan—hypertension	8.07e-06	0.000111	CcSEcCtD
L-DOPA—Nausea—Verapamil—hypertension	8.05e-06	0.000111	CcSEcCtD
L-DOPA—Asthenia—Captopril—hypertension	8.04e-06	0.000111	CcSEcCtD
L-DOPA—Diarrhoea—Trandolapril—hypertension	8.02e-06	0.000111	CcSEcCtD
L-DOPA—Vomiting—Valsartan—hypertension	8.02e-06	0.000111	CcSEcCtD
L-DOPA—Confusional state—Lisinopril—hypertension	8e-06	0.00011	CcSEcCtD
L-DOPA—Diarrhoea—Enalapril—hypertension	7.99e-06	0.00011	CcSEcCtD
L-DOPA—Hypotension—Timolol—hypertension	7.99e-06	0.00011	CcSEcCtD
L-DOPA—Hypersensitivity—Irbesartan—hypertension	7.99e-06	0.00011	CcSEcCtD
L-DOPA—Vomiting—Olmesartan—hypertension	7.98e-06	0.00011	CcSEcCtD
L-DOPA—Rash—Valsartan—hypertension	7.95e-06	0.00011	CcSEcCtD
L-DOPA—Dizziness—Clonidine—hypertension	7.95e-06	0.00011	CcSEcCtD
L-DOPA—Dermatitis—Valsartan—hypertension	7.95e-06	0.00011	CcSEcCtD
L-DOPA—Oedema—Lisinopril—hypertension	7.93e-06	0.00011	CcSEcCtD
L-DOPA—Pruritus—Captopril—hypertension	7.93e-06	0.000109	CcSEcCtD
L-DOPA—Hypersensitivity—Hydrochlorothiazide—hypertension	7.92e-06	0.000109	CcSEcCtD
L-DOPA—Rash—Olmesartan—hypertension	7.92e-06	0.000109	CcSEcCtD
L-DOPA—Insomnia—Ramipril—hypertension	7.91e-06	0.000109	CcSEcCtD
L-DOPA—Dermatitis—Olmesartan—hypertension	7.91e-06	0.000109	CcSEcCtD
L-DOPA—Headache—Valsartan—hypertension	7.9e-06	0.000109	CcSEcCtD
L-DOPA—Diarrhoea—Telmisartan—hypertension	7.88e-06	0.000109	CcSEcCtD
L-DOPA—Headache—Olmesartan—hypertension	7.86e-06	0.000109	CcSEcCtD
L-DOPA—Paraesthesia—Ramipril—hypertension	7.86e-06	0.000108	CcSEcCtD
L-DOPA—Shock—Lisinopril—hypertension	7.81e-06	0.000108	CcSEcCtD
L-DOPA—Asthenia—Perindopril—hypertension	7.8e-06	0.000108	CcSEcCtD
L-DOPA—Dyspnoea—Ramipril—hypertension	7.8e-06	0.000108	CcSEcCtD
L-DOPA—Hypersensitivity—Furosemide—hypertension	7.79e-06	0.000108	CcSEcCtD
L-DOPA—Asthenia—Irbesartan—hypertension	7.78e-06	0.000107	CcSEcCtD
L-DOPA—Somnolence—Ramipril—hypertension	7.78e-06	0.000107	CcSEcCtD
L-DOPA—Thrombocytopenia—Lisinopril—hypertension	7.77e-06	0.000107	CcSEcCtD
L-DOPA—Dizziness—Trandolapril—hypertension	7.76e-06	0.000107	CcSEcCtD
L-DOPA—Insomnia—Timolol—hypertension	7.74e-06	0.000107	CcSEcCtD
L-DOPA—Dizziness—Enalapril—hypertension	7.72e-06	0.000107	CcSEcCtD
L-DOPA—Asthenia—Hydrochlorothiazide—hypertension	7.71e-06	0.000107	CcSEcCtD
L-DOPA—Hypersensitivity—Betaxolol—hypertension	7.71e-06	0.000106	CcSEcCtD
L-DOPA—Dyspepsia—Ramipril—hypertension	7.7e-06	0.000106	CcSEcCtD
L-DOPA—Pruritus—Perindopril—hypertension	7.7e-06	0.000106	CcSEcCtD
L-DOPA—Paraesthesia—Timolol—hypertension	7.68e-06	0.000106	CcSEcCtD
L-DOPA—Pruritus—Irbesartan—hypertension	7.67e-06	0.000106	CcSEcCtD
L-DOPA—Hyperhidrosis—Lisinopril—hypertension	7.67e-06	0.000106	CcSEcCtD
L-DOPA—Diarrhoea—Captopril—hypertension	7.67e-06	0.000106	CcSEcCtD
L-DOPA—Vomiting—Clonidine—hypertension	7.65e-06	0.000106	CcSEcCtD
L-DOPA—Dyspnoea—Timolol—hypertension	7.62e-06	0.000105	CcSEcCtD
L-DOPA—Dizziness—Telmisartan—hypertension	7.62e-06	0.000105	CcSEcCtD
L-DOPA—Pruritus—Hydrochlorothiazide—hypertension	7.61e-06	0.000105	CcSEcCtD
L-DOPA—Decreased appetite—Ramipril—hypertension	7.6e-06	0.000105	CcSEcCtD
L-DOPA—Somnolence—Timolol—hypertension	7.6e-06	0.000105	CcSEcCtD
L-DOPA—Asthenia—Furosemide—hypertension	7.59e-06	0.000105	CcSEcCtD
L-DOPA—Rash—Clonidine—hypertension	7.58e-06	0.000105	CcSEcCtD
L-DOPA—Dermatitis—Clonidine—hypertension	7.57e-06	0.000105	CcSEcCtD
L-DOPA—Anorexia—Lisinopril—hypertension	7.56e-06	0.000104	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Ramipril—hypertension	7.55e-06	0.000104	CcSEcCtD
L-DOPA—Fatigue—Ramipril—hypertension	7.54e-06	0.000104	CcSEcCtD
L-DOPA—Headache—Clonidine—hypertension	7.53e-06	0.000104	CcSEcCtD
L-DOPA—Dyspepsia—Timolol—hypertension	7.53e-06	0.000104	CcSEcCtD
L-DOPA—Hypersensitivity—Losartan—hypertension	7.52e-06	0.000104	CcSEcCtD
L-DOPA—Asthenia—Betaxolol—hypertension	7.51e-06	0.000104	CcSEcCtD
L-DOPA—Liothyronine—ALB—hypertension	7.51e-06	0.00365	CrCbGaD
L-DOPA—Nausea—Valsartan—hypertension	7.49e-06	0.000103	CcSEcCtD
L-DOPA—Pruritus—Furosemide—hypertension	7.48e-06	0.000103	CcSEcCtD
L-DOPA—Constipation—Ramipril—hypertension	7.48e-06	0.000103	CcSEcCtD
L-DOPA—Nausea—Olmesartan—hypertension	7.46e-06	0.000103	CcSEcCtD
L-DOPA—Vomiting—Trandolapril—hypertension	7.46e-06	0.000103	CcSEcCtD
L-DOPA—Diarrhoea—Perindopril—hypertension	7.44e-06	0.000103	CcSEcCtD
L-DOPA—Decreased appetite—Timolol—hypertension	7.43e-06	0.000103	CcSEcCtD
L-DOPA—Vomiting—Enalapril—hypertension	7.43e-06	0.000103	CcSEcCtD
L-DOPA—Diarrhoea—Irbesartan—hypertension	7.42e-06	0.000102	CcSEcCtD
L-DOPA—Hypotension—Lisinopril—hypertension	7.41e-06	0.000102	CcSEcCtD
L-DOPA—Dizziness—Captopril—hypertension	7.41e-06	0.000102	CcSEcCtD
L-DOPA—Pruritus—Betaxolol—hypertension	7.41e-06	0.000102	CcSEcCtD
L-DOPA—Rash—Trandolapril—hypertension	7.39e-06	0.000102	CcSEcCtD
L-DOPA—Dermatitis—Trandolapril—hypertension	7.39e-06	0.000102	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Timolol—hypertension	7.38e-06	0.000102	CcSEcCtD
L-DOPA—Fatigue—Timolol—hypertension	7.37e-06	0.000102	CcSEcCtD
L-DOPA—Rash—Enalapril—hypertension	7.36e-06	0.000102	CcSEcCtD
L-DOPA—Dermatitis—Enalapril—hypertension	7.36e-06	0.000102	CcSEcCtD
L-DOPA—Diarrhoea—Hydrochlorothiazide—hypertension	7.36e-06	0.000102	CcSEcCtD
L-DOPA—Headache—Trandolapril—hypertension	7.35e-06	0.000101	CcSEcCtD
L-DOPA—Vomiting—Telmisartan—hypertension	7.33e-06	0.000101	CcSEcCtD
L-DOPA—Asthenia—Losartan—hypertension	7.32e-06	0.000101	CcSEcCtD
L-DOPA—Headache—Enalapril—hypertension	7.32e-06	0.000101	CcSEcCtD
L-DOPA—Pain—Timolol—hypertension	7.31e-06	0.000101	CcSEcCtD
L-DOPA—Rash—Telmisartan—hypertension	7.26e-06	0.0001	CcSEcCtD
L-DOPA—Dermatitis—Telmisartan—hypertension	7.26e-06	0.0001	CcSEcCtD
L-DOPA—Diarrhoea—Furosemide—hypertension	7.23e-06	9.99e-05	CcSEcCtD
L-DOPA—Pruritus—Losartan—hypertension	7.22e-06	9.97e-05	CcSEcCtD
L-DOPA—Headache—Telmisartan—hypertension	7.22e-06	9.97e-05	CcSEcCtD
L-DOPA—Feeling abnormal—Ramipril—hypertension	7.21e-06	9.95e-05	CcSEcCtD
L-DOPA—Dizziness—Perindopril—hypertension	7.19e-06	9.93e-05	CcSEcCtD
L-DOPA—Insomnia—Lisinopril—hypertension	7.18e-06	9.91e-05	CcSEcCtD
L-DOPA—Dizziness—Irbesartan—hypertension	7.17e-06	9.9e-05	CcSEcCtD
L-DOPA—Diarrhoea—Betaxolol—hypertension	7.16e-06	9.89e-05	CcSEcCtD
L-DOPA—Gastrointestinal pain—Ramipril—hypertension	7.15e-06	9.88e-05	CcSEcCtD
L-DOPA—Nausea—Clonidine—hypertension	7.14e-06	9.86e-05	CcSEcCtD
L-DOPA—Paraesthesia—Lisinopril—hypertension	7.12e-06	9.84e-05	CcSEcCtD
L-DOPA—Vomiting—Captopril—hypertension	7.12e-06	9.84e-05	CcSEcCtD
L-DOPA—Dizziness—Hydrochlorothiazide—hypertension	7.11e-06	9.82e-05	CcSEcCtD
L-DOPA—Dyspnoea—Lisinopril—hypertension	7.07e-06	9.77e-05	CcSEcCtD
L-DOPA—Rash—Captopril—hypertension	7.06e-06	9.75e-05	CcSEcCtD
L-DOPA—Dermatitis—Captopril—hypertension	7.06e-06	9.74e-05	CcSEcCtD
L-DOPA—Somnolence—Lisinopril—hypertension	7.05e-06	9.74e-05	CcSEcCtD
L-DOPA—Feeling abnormal—Timolol—hypertension	7.05e-06	9.73e-05	CcSEcCtD
L-DOPA—Headache—Captopril—hypertension	7.02e-06	9.69e-05	CcSEcCtD
L-DOPA—Gastrointestinal pain—Timolol—hypertension	6.99e-06	9.66e-05	CcSEcCtD
L-DOPA—Dizziness—Furosemide—hypertension	6.99e-06	9.65e-05	CcSEcCtD
L-DOPA—Dyspepsia—Lisinopril—hypertension	6.98e-06	9.64e-05	CcSEcCtD
L-DOPA—Diarrhoea—Losartan—hypertension	6.98e-06	9.64e-05	CcSEcCtD
L-DOPA—Nausea—Trandolapril—hypertension	6.97e-06	9.62e-05	CcSEcCtD
L-DOPA—Urticaria—Ramipril—hypertension	6.95e-06	9.6e-05	CcSEcCtD
L-DOPA—Nausea—Enalapril—hypertension	6.94e-06	9.58e-05	CcSEcCtD
L-DOPA—Dizziness—Betaxolol—hypertension	6.92e-06	9.56e-05	CcSEcCtD
L-DOPA—Vomiting—Perindopril—hypertension	6.92e-06	9.55e-05	CcSEcCtD
L-DOPA—Abdominal pain—Ramipril—hypertension	6.92e-06	9.55e-05	CcSEcCtD
L-DOPA—Decreased appetite—Lisinopril—hypertension	6.9e-06	9.52e-05	CcSEcCtD
L-DOPA—Vomiting—Irbesartan—hypertension	6.89e-06	9.52e-05	CcSEcCtD
L-DOPA—Rash—Perindopril—hypertension	6.86e-06	9.47e-05	CcSEcCtD
L-DOPA—Dermatitis—Perindopril—hypertension	6.85e-06	9.46e-05	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Lisinopril—hypertension	6.85e-06	9.46e-05	CcSEcCtD
L-DOPA—Nausea—Telmisartan—hypertension	6.84e-06	9.45e-05	CcSEcCtD
L-DOPA—Fatigue—Lisinopril—hypertension	6.84e-06	9.44e-05	CcSEcCtD
L-DOPA—Vomiting—Hydrochlorothiazide—hypertension	6.84e-06	9.44e-05	CcSEcCtD
L-DOPA—Rash—Irbesartan—hypertension	6.84e-06	9.44e-05	CcSEcCtD
L-DOPA—Dermatitis—Irbesartan—hypertension	6.83e-06	9.43e-05	CcSEcCtD
L-DOPA—Headache—Perindopril—hypertension	6.81e-06	9.41e-05	CcSEcCtD
L-DOPA—Urticaria—Timolol—hypertension	6.79e-06	9.38e-05	CcSEcCtD
L-DOPA—Headache—Irbesartan—hypertension	6.79e-06	9.38e-05	CcSEcCtD
L-DOPA—Constipation—Lisinopril—hypertension	6.78e-06	9.37e-05	CcSEcCtD
L-DOPA—Pain—Lisinopril—hypertension	6.78e-06	9.37e-05	CcSEcCtD
L-DOPA—Rash—Hydrochlorothiazide—hypertension	6.78e-06	9.36e-05	CcSEcCtD
L-DOPA—Dermatitis—Hydrochlorothiazide—hypertension	6.77e-06	9.35e-05	CcSEcCtD
L-DOPA—Abdominal pain—Timolol—hypertension	6.76e-06	9.34e-05	CcSEcCtD
L-DOPA—Dizziness—Losartan—hypertension	6.75e-06	9.32e-05	CcSEcCtD
L-DOPA—Headache—Hydrochlorothiazide—hypertension	6.74e-06	9.3e-05	CcSEcCtD
L-DOPA—Vomiting—Furosemide—hypertension	6.72e-06	9.28e-05	CcSEcCtD
L-DOPA—Rash—Furosemide—hypertension	6.67e-06	9.21e-05	CcSEcCtD
L-DOPA—Dermatitis—Furosemide—hypertension	6.66e-06	9.2e-05	CcSEcCtD
L-DOPA—Vomiting—Betaxolol—hypertension	6.66e-06	9.19e-05	CcSEcCtD
L-DOPA—Nausea—Captopril—hypertension	6.65e-06	9.19e-05	CcSEcCtD
L-DOPA—Headache—Furosemide—hypertension	6.62e-06	9.15e-05	CcSEcCtD
L-DOPA—Rash—Betaxolol—hypertension	6.6e-06	9.11e-05	CcSEcCtD
L-DOPA—Dermatitis—Betaxolol—hypertension	6.59e-06	9.11e-05	CcSEcCtD
L-DOPA—Headache—Betaxolol—hypertension	6.56e-06	9.06e-05	CcSEcCtD
L-DOPA—Feeling abnormal—Lisinopril—hypertension	6.54e-06	9.03e-05	CcSEcCtD
L-DOPA—Gastrointestinal pain—Lisinopril—hypertension	6.49e-06	8.96e-05	CcSEcCtD
L-DOPA—Vomiting—Losartan—hypertension	6.49e-06	8.96e-05	CcSEcCtD
L-DOPA—Nausea—Perindopril—hypertension	6.46e-06	8.92e-05	CcSEcCtD
L-DOPA—Hypersensitivity—Ramipril—hypertension	6.45e-06	8.9e-05	CcSEcCtD
L-DOPA—Nausea—Irbesartan—hypertension	6.44e-06	8.89e-05	CcSEcCtD
L-DOPA—Rash—Losartan—hypertension	6.43e-06	8.88e-05	CcSEcCtD
L-DOPA—Dermatitis—Losartan—hypertension	6.43e-06	8.87e-05	CcSEcCtD
L-DOPA—Headache—Losartan—hypertension	6.39e-06	8.83e-05	CcSEcCtD
L-DOPA—Nausea—Hydrochlorothiazide—hypertension	6.39e-06	8.82e-05	CcSEcCtD
L-DOPA—Urticaria—Lisinopril—hypertension	6.3e-06	8.7e-05	CcSEcCtD
L-DOPA—Hypersensitivity—Timolol—hypertension	6.3e-06	8.7e-05	CcSEcCtD
L-DOPA—Nausea—Furosemide—hypertension	6.28e-06	8.67e-05	CcSEcCtD
L-DOPA—Asthenia—Ramipril—hypertension	6.28e-06	8.67e-05	CcSEcCtD
L-DOPA—Abdominal pain—Lisinopril—hypertension	6.27e-06	8.66e-05	CcSEcCtD
L-DOPA—Nausea—Betaxolol—hypertension	6.22e-06	8.59e-05	CcSEcCtD
L-DOPA—Pruritus—Ramipril—hypertension	6.19e-06	8.55e-05	CcSEcCtD
L-DOPA—Asthenia—Timolol—hypertension	6.14e-06	8.47e-05	CcSEcCtD
L-DOPA—Nausea—Losartan—hypertension	6.06e-06	8.37e-05	CcSEcCtD
L-DOPA—Pruritus—Timolol—hypertension	6.05e-06	8.35e-05	CcSEcCtD
L-DOPA—Diarrhoea—Ramipril—hypertension	5.99e-06	8.26e-05	CcSEcCtD
L-DOPA—Diarrhoea—Timolol—hypertension	5.85e-06	8.08e-05	CcSEcCtD
L-DOPA—Hypersensitivity—Lisinopril—hypertension	5.85e-06	8.07e-05	CcSEcCtD
L-DOPA—Dizziness—Ramipril—hypertension	5.78e-06	7.99e-05	CcSEcCtD
L-DOPA—Asthenia—Lisinopril—hypertension	5.69e-06	7.86e-05	CcSEcCtD
L-DOPA—Dizziness—Timolol—hypertension	5.66e-06	7.81e-05	CcSEcCtD
L-DOPA—Pruritus—Lisinopril—hypertension	5.61e-06	7.75e-05	CcSEcCtD
L-DOPA—Vomiting—Ramipril—hypertension	5.56e-06	7.68e-05	CcSEcCtD
L-DOPA—Rash—Ramipril—hypertension	5.52e-06	7.62e-05	CcSEcCtD
L-DOPA—Dermatitis—Ramipril—hypertension	5.51e-06	7.61e-05	CcSEcCtD
L-DOPA—Headache—Ramipril—hypertension	5.48e-06	7.57e-05	CcSEcCtD
L-DOPA—Vomiting—Timolol—hypertension	5.44e-06	7.51e-05	CcSEcCtD
L-DOPA—Diarrhoea—Lisinopril—hypertension	5.43e-06	7.5e-05	CcSEcCtD
L-DOPA—Rash—Timolol—hypertension	5.39e-06	7.45e-05	CcSEcCtD
L-DOPA—Dermatitis—Timolol—hypertension	5.39e-06	7.44e-05	CcSEcCtD
L-DOPA—Headache—Timolol—hypertension	5.36e-06	7.4e-05	CcSEcCtD
L-DOPA—Dizziness—Lisinopril—hypertension	5.25e-06	7.24e-05	CcSEcCtD
L-DOPA—Nausea—Ramipril—hypertension	5.2e-06	7.17e-05	CcSEcCtD
L-DOPA—Nausea—Timolol—hypertension	5.08e-06	7.01e-05	CcSEcCtD
L-DOPA—Vomiting—Lisinopril—hypertension	5.04e-06	6.97e-05	CcSEcCtD
L-DOPA—Rash—Lisinopril—hypertension	5e-06	6.91e-05	CcSEcCtD
L-DOPA—Dermatitis—Lisinopril—hypertension	5e-06	6.9e-05	CcSEcCtD
L-DOPA—Headache—Lisinopril—hypertension	4.97e-06	6.86e-05	CcSEcCtD
L-DOPA—Nausea—Lisinopril—hypertension	4.71e-06	6.51e-05	CcSEcCtD
L-DOPA—DRD3—Signaling Pathways—HIF1A—hypertension	7.43e-07	1.61e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—AGT—hypertension	7.4e-07	1.61e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—SLC9A1—hypertension	7.38e-07	1.6e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—GSTT1—hypertension	7.38e-07	1.6e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CALM1—hypertension	7.37e-07	1.6e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CXCL8—hypertension	7.35e-07	1.6e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—APOE—hypertension	7.35e-07	1.6e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—LEP—hypertension	7.35e-07	1.6e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TGFBR2—hypertension	7.34e-07	1.59e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CETP—hypertension	7.3e-07	1.58e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—GCLC—hypertension	7.3e-07	1.58e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CAV1—hypertension	7.28e-07	1.58e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CALM1—hypertension	7.27e-07	1.58e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—GNB3—hypertension	7.27e-07	1.58e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—APOA1—hypertension	7.26e-07	1.58e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—LEP—hypertension	7.25e-07	1.57e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—APOE—hypertension	7.25e-07	1.57e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—KDR—hypertension	7.2e-07	1.56e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CAV1—hypertension	7.18e-07	1.56e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—AVP—hypertension	7.17e-07	1.56e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—APOA1—hypertension	7.17e-07	1.56e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—RHOA—hypertension	7.11e-07	1.54e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—KDR—hypertension	7.1e-07	1.54e-05	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—AKT1—hypertension	7.1e-07	1.54e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—GNAS—hypertension	7.08e-07	1.54e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—PIK3R1—hypertension	7.03e-07	1.53e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—POMC—hypertension	7.01e-07	1.52e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CYP17A1—hypertension	6.99e-07	1.52e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—IL6—hypertension	6.99e-07	1.52e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—INS—hypertension	6.97e-07	1.51e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—APOB—hypertension	6.93e-07	1.5e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—PRKCB—hypertension	6.93e-07	1.5e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—F2—hypertension	6.93e-07	1.5e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—FN1—hypertension	6.93e-07	1.5e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PTGS1—hypertension	6.92e-07	1.5e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ENO1—hypertension	6.92e-07	1.5e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PTK2—hypertension	6.9e-07	1.5e-05	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CXCL8—hypertension	6.87e-07	1.49e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CCL2—hypertension	6.86e-07	1.49e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—F2—hypertension	6.84e-07	1.48e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—FN1—hypertension	6.84e-07	1.48e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—PRKCB—hypertension	6.84e-07	1.48e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—EDN1—hypertension	6.82e-07	1.48e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NOTCH1—hypertension	6.78e-07	1.47e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CCL5—hypertension	6.77e-07	1.47e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IGF1—hypertension	6.74e-07	1.46e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—AKT2—hypertension	6.74e-07	1.46e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—EGFR—hypertension	6.71e-07	1.46e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NOTCH1—hypertension	6.69e-07	1.45e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CTGF—hypertension	6.66e-07	1.45e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—MMP9—hypertension	6.65e-07	1.44e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CDKN1A—hypertension	6.62e-07	1.44e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—LPL—hypertension	6.62e-07	1.44e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—PTEN—hypertension	6.61e-07	1.43e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—HMGCR—hypertension	6.6e-07	1.43e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—GOT2—hypertension	6.6e-07	1.43e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—H2AFX—hypertension	6.57e-07	1.43e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PDGFRB—hypertension	6.56e-07	1.42e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—RPS6KB1—hypertension	6.56e-07	1.42e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—ADCY5—hypertension	6.48e-07	1.41e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—MAPK8—hypertension	6.46e-07	1.4e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ADRA2A—hypertension	6.46e-07	1.4e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—AKT1—hypertension	6.45e-07	1.4e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PRKCG—hypertension	6.43e-07	1.4e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—SERPINE1—hypertension	6.4e-07	1.39e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PRKCA—hypertension	6.39e-07	1.39e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—ITGB3—hypertension	6.39e-07	1.39e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—YWHAZ—hypertension	6.34e-07	1.38e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—POMC—hypertension	6.31e-07	1.37e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—EP300—hypertension	6.3e-07	1.37e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—INS—hypertension	6.28e-07	1.36e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—SPP1—hypertension	6.27e-07	1.36e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NGF—hypertension	6.27e-07	1.36e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CXCL8—hypertension	6.24e-07	1.35e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—POMC—hypertension	6.23e-07	1.35e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—FGF2—hypertension	6.2e-07	1.35e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—INS—hypertension	6.19e-07	1.34e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—RHOA—hypertension	6.18e-07	1.34e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CCL2—hypertension	6.17e-07	1.34e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—SRC—hypertension	6.13e-07	1.33e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—NOS3—hypertension	6.11e-07	1.33e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—PIK3R1—hypertension	6.11e-07	1.33e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PRKCD—hypertension	6.1e-07	1.32e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CCR5—hypertension	6.1e-07	1.32e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CCL2—hypertension	6.09e-07	1.32e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IGF1—hypertension	6.07e-07	1.32e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—AKT2—hypertension	6.07e-07	1.32e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—TH—hypertension	6.05e-07	1.31e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—EGFR—hypertension	6.04e-07	1.31e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CALM2—hypertension	6.03e-07	1.31e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IGF1—hypertension	5.99e-07	1.3e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—AKT2—hypertension	5.99e-07	1.3e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—VEGFA—hypertension	5.97e-07	1.3e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—HTR2A—hypertension	5.97e-07	1.3e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—EGFR—hypertension	5.96e-07	1.29e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—C3—hypertension	5.96e-07	1.29e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—GCG—hypertension	5.88e-07	1.28e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—SLC2A4—hypertension	5.88e-07	1.28e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PDGFB—hypertension	5.8e-07	1.26e-05	CbGpPWpGaD
L-DOPA—DDC—Metabolism—AKT1—hypertension	5.79e-07	1.26e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—FGFR1—hypertension	5.77e-07	1.25e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—SERPINE1—hypertension	5.76e-07	1.25e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—RELA—hypertension	5.75e-07	1.25e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—GOT1—hypertension	5.7e-07	1.24e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—SERPINE1—hypertension	5.69e-07	1.24e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—HIF1A—hypertension	5.68e-07	1.23e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—AGT—hypertension	5.66e-07	1.23e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—MTOR—hypertension	5.64e-07	1.23e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—FGF2—hypertension	5.58e-07	1.21e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CALM1—hypertension	5.57e-07	1.21e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—RHOA—hypertension	5.56e-07	1.21e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—APOE—hypertension	5.55e-07	1.2e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—LEP—hypertension	5.55e-07	1.2e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—STK11—hypertension	5.53e-07	1.2e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CYP19A1—hypertension	5.53e-07	1.2e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—FGF2—hypertension	5.51e-07	1.2e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—PIK3R1—hypertension	5.5e-07	1.2e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NOS3—hypertension	5.5e-07	1.2e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CAV1—hypertension	5.5e-07	1.19e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—MYC—hypertension	5.49e-07	1.19e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—RHOA—hypertension	5.49e-07	1.19e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—APOA1—hypertension	5.48e-07	1.19e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—TGFB1—hypertension	5.48e-07	1.19e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—KDR—hypertension	5.43e-07	1.18e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—PIK3R1—hypertension	5.43e-07	1.18e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NOS3—hypertension	5.43e-07	1.18e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CXCL8—hypertension	5.42e-07	1.18e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—EGFR—hypertension	5.37e-07	1.17e-05	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—AKT1—hypertension	5.24e-07	1.14e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—F2—hypertension	5.23e-07	1.14e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PRKCB—hypertension	5.23e-07	1.14e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—FN1—hypertension	5.23e-07	1.14e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—RELA—hypertension	5.18e-07	1.12e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—IL6—hypertension	5.16e-07	1.12e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—COMT—hypertension	5.14e-07	1.12e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NOTCH1—hypertension	5.12e-07	1.11e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—RELA—hypertension	5.11e-07	1.11e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—MTOR—hypertension	5.08e-07	1.1e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PPARGC1A—hypertension	5.07e-07	1.1e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—GNB3—hypertension	5.07e-07	1.1e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—HMOX1—hypertension	5.05e-07	1.1e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—MTOR—hypertension	5.01e-07	1.09e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CAT—hypertension	4.98e-07	1.08e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—GNAS—hypertension	4.94e-07	1.07e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—MMP9—hypertension	4.9e-07	1.07e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CDKN1A—hypertension	4.89e-07	1.06e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CXCL8—hypertension	4.88e-07	1.06e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—PTEN—hypertension	4.88e-07	1.06e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—APOB—hypertension	4.83e-07	1.05e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CXCL8—hypertension	4.82e-07	1.05e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—MAPK8—hypertension	4.77e-07	1.04e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—POMC—hypertension	4.76e-07	1.03e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—AKT1—hypertension	4.76e-07	1.03e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—INS—hypertension	4.74e-07	1.03e-05	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—AKT1—hypertension	4.72e-07	1.02e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—GSTM1—hypertension	4.7e-07	1.02e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CCL2—hypertension	4.66e-07	1.01e-05	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—AKT1—hypertension	4.65e-07	1.01e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—EP300—hypertension	4.65e-07	1.01e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—IL6—hypertension	4.64e-07	1.01e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—LPL—hypertension	4.62e-07	1e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IGF1—hypertension	4.58e-07	9.95e-06	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—IL6—hypertension	4.58e-07	9.95e-06	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—AKT2—hypertension	4.58e-07	9.94e-06	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—EGFR—hypertension	4.56e-07	9.9e-06	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—SRC—hypertension	4.52e-07	9.82e-06	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ADCY5—hypertension	4.52e-07	9.81e-06	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—TP53—hypertension	4.51e-07	9.79e-06	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—GPX1—hypertension	4.5e-07	9.78e-06	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PRKCA—hypertension	4.46e-07	9.68e-06	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CYP1A1—hypertension	4.46e-07	9.68e-06	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—MMP9—hypertension	4.42e-07	9.59e-06	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—VEGFA—hypertension	4.4e-07	9.56e-06	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CDKN1A—hypertension	4.4e-07	9.55e-06	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—PTEN—hypertension	4.39e-07	9.53e-06	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CD36—hypertension	4.39e-07	9.52e-06	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—MMP9—hypertension	4.36e-07	9.46e-06	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—SERPINE1—hypertension	4.35e-07	9.45e-06	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CDKN1A—hypertension	4.34e-07	9.43e-06	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—PTEN—hypertension	4.33e-07	9.41e-06	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—MAPK8—hypertension	4.29e-07	9.32e-06	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—AKT1—hypertension	4.28e-07	9.3e-06	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—MAPK8—hypertension	4.24e-07	9.2e-06	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—AKT1—hypertension	4.23e-07	9.18e-06	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—FGF2—hypertension	4.21e-07	9.15e-06	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—RHOA—hypertension	4.2e-07	9.12e-06	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—EP300—hypertension	4.19e-07	9.09e-06	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—MTHFR—hypertension	4.16e-07	9.02e-06	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NOS3—hypertension	4.16e-07	9.02e-06	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PIK3R1—hypertension	4.16e-07	9.02e-06	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—EP300—hypertension	4.13e-07	8.97e-06	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IL6—hypertension	4.13e-07	8.96e-06	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PPARA—hypertension	4.08e-07	8.85e-06	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—SRC—hypertension	4.07e-07	8.84e-06	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—MYC—hypertension	4.05e-07	8.8e-06	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—TGFB1—hypertension	4.04e-07	8.78e-06	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—SRC—hypertension	4.02e-07	8.72e-06	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—VEGFA—hypertension	3.96e-07	8.61e-06	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—EGFR—hypertension	3.96e-07	8.61e-06	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—AGT—hypertension	3.95e-07	8.57e-06	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—VEGFA—hypertension	3.91e-07	8.49e-06	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—RELA—hypertension	3.91e-07	8.49e-06	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CALM1—hypertension	3.88e-07	8.43e-06	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—APOE—hypertension	3.87e-07	8.4e-06	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—MTOR—hypertension	3.84e-07	8.33e-06	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CAV1—hypertension	3.83e-07	8.32e-06	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—APOA1—hypertension	3.82e-07	8.31e-06	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—AKT1—hypertension	3.81e-07	8.27e-06	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CXCL8—hypertension	3.69e-07	8e-06	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—MYC—hypertension	3.65e-07	7.92e-06	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TGFB1—hypertension	3.64e-07	7.9e-06	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—MYC—hypertension	3.6e-07	7.82e-06	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TGFB1—hypertension	3.59e-07	7.8e-06	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—EGFR—hypertension	3.57e-07	7.75e-06	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—AKT1—hypertension	3.56e-07	7.73e-06	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—EGFR—hypertension	3.52e-07	7.64e-06	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—IL6—hypertension	3.5e-07	7.61e-06	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PPARG—hypertension	3.37e-07	7.32e-06	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—MMP9—hypertension	3.33e-07	7.24e-06	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—TP53—hypertension	3.33e-07	7.23e-06	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—POMC—hypertension	3.32e-07	7.22e-06	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CDKN1A—hypertension	3.32e-07	7.21e-06	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PTEN—hypertension	3.31e-07	7.2e-06	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—INS—hypertension	3.31e-07	7.18e-06	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—MAPK8—hypertension	3.24e-07	7.04e-06	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—AKT1—hypertension	3.23e-07	7.02e-06	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—EP300—hypertension	3.16e-07	6.86e-06	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—SRC—hypertension	3.07e-07	6.67e-06	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IL6—hypertension	3.05e-07	6.61e-06	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ALB—hypertension	3.03e-07	6.58e-06	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TP53—hypertension	3e-07	6.51e-06	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—VEGFA—hypertension	2.99e-07	6.5e-06	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TP53—hypertension	2.96e-07	6.42e-06	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—NOS3—hypertension	2.9e-07	6.29e-06	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PIK3R1—hypertension	2.9e-07	6.29e-06	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—AKT1—hypertension	2.81e-07	6.1e-06	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—MYC—hypertension	2.75e-07	5.98e-06	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TGFB1—hypertension	2.75e-07	5.97e-06	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IL6—hypertension	2.74e-07	5.95e-06	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IL6—hypertension	2.71e-07	5.88e-06	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—EGFR—hypertension	2.69e-07	5.85e-06	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PTGS2—hypertension	2.65e-07	5.76e-06	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—AKT1—hypertension	2.53e-07	5.49e-06	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—AKT1—hypertension	2.5e-07	5.42e-06	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PTEN—hypertension	2.31e-07	5.02e-06	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TP53—hypertension	2.26e-07	4.91e-06	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—EP300—hypertension	2.2e-07	4.79e-06	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IL6—hypertension	2.07e-07	4.5e-06	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—AKT1—hypertension	1.91e-07	4.15e-06	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—AKT1—hypertension	1.33e-07	2.89e-06	CbGpPWpGaD
